PNC Financial Services Group
ADPT icon

PNC Financial Services Group’s Adaptive Biotechnologies ADPT Stock Holding History

PNC Financial Services Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
12,114
-2,623
-18% -$40.2K ﹤0.01% 2264
2026
Q1 		$205K Buy
14,737
+941
+7% +$15K ﹤0.01% 2298
2025
Q4 		$224K Buy
13,796
+12,058
+694% +$197K ﹤0.01% 2221
2025
Q3 		$26K Buy
1,738
+60
+4% +$731 ﹤0.01% 3530
2025
Q2 		$19.5K Buy
1,678
+297
+22% +$2.7K ﹤0.01% 3582
2025
Q1 		$10.3K Buy
1,381
+14
+1% +$108 ﹤0.01% 3814
2024
Q4 		$8.2K Sell
1,367
-1,625
-54% -$8.96K ﹤0.01% 3867
2024
Q3 		$15.3K Sell
2,992
-4,400
-60% -$19.2K ﹤0.01% 3633
2024
Q2 		$26.8K Sell
7,392
-2,037
-22% -$6.47K ﹤0.01% 3336
2024
Q1 		$30.3K Buy
9,429
+1,615
+21% +$6.25K ﹤0.01% 3235
2023
Q4 		$38.3K Sell
7,814
-328
-4% -$1.5K ﹤0.01% 3098
2023
Q3 		$44.4K Sell
8,142
-290
-3% -$1.92K ﹤0.01% 3024
2023
Q2 		$56.6K Buy
8,432
+1,587
+23% +$11.8K ﹤0.01% 2989
2023
Q1 		$60.4K Sell
6,845
-41
-0.6% -$361 ﹤0.01% 2876
2022
Q4 		$52.6K Sell
6,886
-1,990
-22% -$15.5K ﹤0.01% 2954
2022
Q3 		$64K Buy
8,876
+4,977
+128% +$46.9K ﹤0.01% 2808
2022
Q2 		$32K Sell
3,899
-1,394
-26% -$12.3K ﹤0.01% 3245
2022
Q1 		$73K Buy
5,293
+3,380
+177% +$53.1K ﹤0.01% 2889
2021
Q4 		$53K Sell
1,913
-3,333
-64% -$102K ﹤0.01% 3076
2021
Q3 		$179K Sell
5,246
-2,472
-32% -$89.4K ﹤0.01% 2266
2021
Q2 		$315K Sell
7,718
-2,042
-21% -$79.4K ﹤0.01% 1934
2021
Q1 		$393K Sell
9,760
-164
-2% -$8.88K ﹤0.01% 1735
2020
Q4 		$588K Buy
9,924
+3,562
+56% +$184K ﹤0.01% 1381
2020
Q3 		$309K Sell
6,362
-273
-4% -$11.5K ﹤0.01% 1655
2020
Q2 		$322K Buy
6,635
+5,986
+922% +$218K ﹤0.01% 1632
2020
Q1 		$18K Buy
649
+11
+2% +$307 ﹤0.01% 3160
2019
Q4 		$19K Sell
638
-3
-0.5% -$86 ﹤0.01% 3326
2019
Q3 		$20K Buy
+641
New +$26.2K ﹤0.01% 3341

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PNC Financial Services Group's ADPT Position: Q2 2026 in Review

PNC Financial Services Group reduced its Adaptive Biotechnologies (ADPT) stake by 18% in Q2 2026, selling an estimated $40.2K and leaving 12,114 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

PNC Financial Services Group first reported a position in ADPT in Q3 2019 and has held it in 28 quarters since. The position peaked at $588K in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • PNC Financial Services Group held 12,114 shares of Adaptive Biotechnologies worth $260K as of Q2 2026.
  • PNC Financial Services Group sold 2,623 Adaptive Biotechnologies shares in Q2 2026, an estimated $40.2K.
  • Adaptive Biotechnologies made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2264 holding.
  • PNC Financial Services Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 28 quarters since.
  • PNC Financial Services Group's Adaptive Biotechnologies position peaked at $588K in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.